Corning (NYSE:GLW) may be known for its Gorilla Glass and Pyrex brands, but I believe one of its lesser-known brands, Valor Glass, will be in the spotlight going forward. The world is in a rush to develop and mass-produce an effective vaccine for COVID-19, but once it's ready, billions of glass vials will be needed to safely transport and administer it. This surge in demand will require a significant increase in production capacity. Corning is one of the few companies with the potential to fill the extra demand, and I believe that will be a huge boost to its business.
Company Overview
Corning Inc., founded 169 years ago, is one of the oldest and most recognized American companies. The company is a leading innovator in material sciences with a focus on specialty glass, ceramics, and related materials. It has several well-known brands, like Gorilla Glass, Pyrex, Falcon, Axygen, and others.
In 2019, the company reported total sales of $11.5 billion, with five reportable segments: Display Technologies, Optical Communications, Specialty Materials, Environmental Technologies, and Life Sciences. The company has a wide range of products and patents, as well as a solid track record with its R&D investments, which should translate into solid long-term growth.
Among its most important products is Gorilla Glass, which is used in several smartphones, including the iPhone. In 2019, Gorilla Glass sales totaled $1,180 million (10.1% of net sales). With 5G deployment on the way, many consumers will look to upgrade their phones, which should result in higher Gorilla Glass sales. Corning will surely look to capitalize on this new smartphone cycle. Nonetheless, I believe the biggest catalyst going forward will be the development of its Valor Glass brand.
Glass Vial Shortage and Valor Glass
Glass Vial Shortages
Since the start of the